Simulations Plus, Inc. (NASDAQ:SLP) will be hosting a conference call at 4:15 PM eastern time on 16th November 2020, to discuss its 4Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.simulations-plus.com
The participants may dial, (213) 929-4232 Toll Free, (United States) in order to access the live audio call
Earnings Expectation
Simulations Plus, Inc. developer of drug discovery and development software, is expected to report fourth quarter earnings results, after market close, on Monday 16th November 2020. Analysts polled by Thomson Reuters anticipate fourth quarter income of $ 0.09 per share from revenue of $ 9.38 million. Looking ahead, the full year income are expected at $ 0.47 per share on the revenues of $ 41.42 million.
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
